NewGenIvf, a fertility services provider in Asia, and A SPAC I Acquisition announced the completion of their merger.
NewGenIvf Group shares and warrants are expected to begin trading today on the Nasdaq under the tickers NIVF and NIVFW.
A SPAC I shareholders approved the deal nearly three weeks ago.
The deal was announced in February 2023 at an implied enterprise value of approximately $50 million. A SPAC I raised $60 millon in 2022 IPO a year ago, although the trust was down to about $37.3 million following redemptions on an extension vote.
NewGenIvf fertility clinics primarily serve patients in Southeast Asia across three jurisdictions: Thailand, Cambodia, and Kyrgyzstan. Read more.
